Department of Cardio-thoracic surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Clinic for Pediatric Cardiac Surgery and Congenital Heart Defects, Heart and Diabetes Centre North Rhine-Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany.
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac381.
Ventricular assist device support as a bridge to transplant or recovery is a well-established therapy in children on the cardiac transplant waiting list. The goal of this study was to investigate the incidence of and the associated factors for cerebrovascular accidents in paediatric patients supported by a Berlin Heart EXCOR.
All patients <19 years of age supported by a Berlin Heart EXCOR between January 2011 and January 2021 from the European Registry for Patients with Mechanical Circulatory Support were included.
In total, 230 patients were included. A total of 140 (60.9%) patients had a diagnosis of dilated cardiomyopathy. 46 patients (20.0%) sustained 55 cerebrovascular accidents, with 70.9% of the episodes within 90 days after the ventricular assist device was implanted. The event rate of cerebrovascular accidents was highest in the first era (0.75). Pump thrombosis and secondary need for a right ventricular assist device were found to be associated with a cerebrovascular accident (hazard ratio 1.998, P = 0.040; hazard ratio 11.300, P = 0.037). At the 1-year follow-up, 44.4% of the patients had received a transplant, 13.1% were weaned after recovery and 24.5% had died. Event rates for mortality showed a significantly decreasing trend.
Paediatric ventricular assist device support is associated with important adverse events, especially in the early phase after the device is implanted. Pump thrombosis and the need for a secondary right ventricular assist device are associated with cerebrovascular accidents. Furthermore, an encouragingly high rate of recovery in this patient population was shown, and death rates declined. More complete input of data into the registry, especially concerning anticoagulation protocols, would improve the data.
心室辅助装置(VAD)作为移植或恢复的桥接治疗,在心脏移植等待名单上的儿童中已得到广泛应用。本研究旨在调查柏林心脏 EXCOR 支持的儿科患者发生脑血管意外的发生率及相关因素。
纳入 2011 年 1 月至 2021 年 1 月期间欧洲机械循环支持患者登记处中接受柏林心脏 EXCOR 支持的年龄均小于 19 岁的所有患者。
共纳入 230 例患者。其中 140 例(60.9%)患者被诊断为扩张型心肌病,46 例(20.0%)患者发生了 55 次脑血管意外,其中 70.9%的事件发生在 VAD 植入后 90 天内。第一个时期的脑血管意外发生率最高(0.75)。发现泵血栓形成和对右心室辅助装置的二次需求与脑血管意外有关(风险比 1.998,P=0.040;风险比 11.300,P=0.037)。在 1 年随访时,44.4%的患者接受了移植,13.1%的患者在恢复后脱机,24.5%的患者死亡。死亡率的发生率呈明显下降趋势。
儿科 VAD 支持与重要的不良事件相关,尤其是在装置植入后的早期阶段。泵血栓形成和对二次右心室辅助装置的需求与脑血管意外有关。此外,该患者人群的恢复率较高,死亡率下降。更完整地向登记处输入数据,特别是关于抗凝方案,将改善数据。